Idorsia | OnDemand Investor Webcast

Search

Search
Share
Share
Facebook

Twitter

LinkedIn

Mail
Location
Location
North America

Europe

Asia

Idorsia is expanding its global footprint to reach more patients with our transformative treatments.
We conduct research, clinical development and commercial operations out of the following locations. Click the pin to find out more. Click the arrows to navigate across geographies.
Click the pin to find out more.

Idorsia Pharmaceuticals Ltd

Hegenheimermattweg 91
4123 Allschwil
Switzerland

Idorsia Pharmaceuticals Ltd

Hegenheimermattweg 91
4123 Allschwil
Switzerland

Headquarters of Idorsia Ltd.
Responsible for drug discovery, development, registration, production, quality assurance, safety, as well as company management and coordination.

www.idorsia.com

Contact us online

Idorsia (Berlin) Pharmaceuticals GmbH

Magnusstrasse 11
D-12489 Berlin
Germany

A 100% subsidiary of Idorsia Pharmaceuticals Ltd, based in Berlin, Germany
– discovers and develops synthetic carbohydrate vaccines to prevent infection.

Idorsia Pharmaceuticals Deutschland GmbH

Marie-Curie-Strasse 8
DE-79539 Lörrach
Germany

A 100% subsidiary of Idorsia Ltd, based in Lörrach, Germany
– performs clinical development on behalf of the Group and acts as Idorsia’s representative for obtaining regulatory approvals in the EU.

Idorsia Pharmaceuticals UK Limited

20 Eastbourne Terrace London,
W2 6LG
United Kingdom

A 100% subsidiary of Idorsia Ltd, based in London, United Kingdom
– is responsible for the Group’s marketing operations in the United Kingdom.

Idorsia Pharmaceuticals Spain S.L.

Paseo Castellana 79
ES-28046 Madrid
Spain

A 100% subsidiary of Idorsia Ltd, based in Madrid, Spain
– is responsible for the Group’s marketing in Spain.

Idorsia Pharmaceuticals Canada Ltd.

220-6500 RTE Transcanadienne
Pointe Claire, Quebec
H9R0A5
Canada

Based in Montreal, Canada
– responsible for the Idorsia’s commercial operations in Canada.

Idorsia Pharmaceuticals Germany GmbH

Dachauerstr. 63
80335 München
Germany

A 100% subsidiary of Idorsia Ltd, based in Munich, Germany
– is responsible for the Group’s marketing operations in Germany.

Idorsia Pharmaceuticals France SAS

Immeuble Colisée Gardens -
Bâtiment B
8-14 Avenue de l'Arche
FR-92400 Courbevoie
France

A 100% subsidiary of Idorsia Ltd, based in Paris, France
– will be responsible for the Group’s marketing operations in France.

Idorsia Pharmaceuticals US Inc.

One Radnor Corporate Center, Suite 101
100 Matsonford Rd
Radnor, PA 19087
United States

Based in Radnor, Pennsylvania, US
– is responsible for the commercial operations in the US.
– performs clinical development on behalf of Idorsia.

Idorsia Pharmaceuticals Nordics AB

c/o FirstOffice
Gustav III's Boulevard 46
169 73 Solna
Sweden

A 100% subsidiary of Idorsia Ltd, based in Stockholm, Sweden
– responsible for the Idorsia’s commercial operations in Sweden, Norway, Finland, and Denmark.

Idorsia Pharmaceuticals Italy S.r.l.

Via Fabio Filzi 25A
20124 Milan
Italy

Idorsia (Shanghai) Pharmaceuticals Co., Ltd

Room 311, No. 6, Lane 368
Lushuo Road
Shanghai
China

Based in Shanghai, PRC
– performs research and development on behalf of Idorsia.
Contact
Contact
General Contact

General Contact:

Idorsia Pharmaceuticals Ltd
Hegenheimermattweg 91
4123 Allschwil
Switzerland

+41 58 844 00 00

Please get in touch with us via the contact form by clicking "Next".

For patients and healthcare professionals

Investor Relations

Media Relations

Business Development

Whistleblower hotline

Whistleblower hotline:

Switzerland: 0800 110 007

USA: (833) 222-3891 (anonymous reporting channel)

Outside Switzerland and USA: +41 58 844 0106

Learn more about our Governance by clicking "Next"

Data Protection Officer

Data Protection Officer:

Idorsia attempts to ensure that your Personal Data are updated, accurate, and complete according to the information that has been provided. Any request related to the exercise of your privacy rights can be sent through the link below.

Webmaster

Stay informed

Stay informed:

To best serve your interest, Idorsia offers an electronic ‘Stay Informed’ service. With this service you have the possibility to automatically receive Idorsia's Media Releases directly to your inbox. In addition, if you provide your mobile phone number, we will send you an alert via SMS when the media release is published.

Home
About Idorsia
Our Innovation
Sustainability
Investors
Media
Careers

Results Day Center
Financial Information
Corporate Reports
News & Events
News & Events
Stock information
Stock information
- Stock overview
- Stock chart tools
Governance

Additional resources

Investor presentation slides
Investor presentation transcript
Media release

Executive summary

Don't have 21 minutes? Watch the 5 minute executive summary...

Watch the executive summary

This website is subject to the terms and conditions outlined in the legal and privacy statement.

Terms and conditions Privacy Policy Data Notice Site map

Copyright © 2025 Idorsia Pharmaceuticals Ltd